miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation

McDonald, Robert A. and White, Katie M. and Wu, Junxi and Cooley, Brian C. and Robertson, Keith E. and Halliday, Crawford A. and McClure, John D. and Francis, Sheila and Lu, Ruifaug and Kennedy, Simon and George, Sarah J. and Wan, Song and Van Rooij, Eva and Baker, Andrew H. (2013) miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation. European Heart Journal, 34 (12). 1636–1643. ISSN 0195-668X (https://doi.org/10.1093/eurheartj/eht105)

[thumbnail of McDonald-etal-EHJ2013-miRNA-21-dysregulated-response-vein-grafting-multiple-models-genetic-ablation-mice]
Text. Filename: McDonald_etal_EHJ2013_miRNA_21_dysregulated_response_vein_grafting_multiple_models_genetic_ablation_mice.pdf
Final Published Version
License: Creative Commons Attribution-NonCommercial 3.0 logo

Download (1MB)| Preview


Aims The long-term failure of autologous saphenous vein bypass grafts due to neointimal thickening is a major clinical burden. Identifying novel strategies to prevent neointimal thickening is important. Thus, this study aimed to identify microRNAs (miRNAs) that are dysregulated during neointimal formation and determine their pathophysiological relevance following miRNA manipulation. Methods and results We undertook a microarray approach to identify dysregulated miRNAs following engraftment in an interpositional porcine graft model. These profiling experiments identified a number of miRNAs which were dysregulated following engraftment. miR-21 levels were substantially elevated following engraftment and these results were confirmed by quantitative real-time PCR in mouse, pig, and human models of vein graft neointimal formation. Genetic ablation of miR-21 in mice or grafted veins dramatically reduced neointimal formation in a mouse model of vein grafting. Furthermore, pharmacological knockdown of miR-21 in human veins resulted in target gene de-repression and a significant reduction in neointimal formation. Conclusion This is the first report demonstrating that miR-21 plays a pathological role in vein graft failure. Furthermore, we also provided evidence that knockdown of miR-21 has therapeutic potential for the prevention of pathological vein graft remodelling.


McDonald, Robert A., White, Katie M., Wu, Junxi ORCID logoORCID: https://orcid.org/0000-0002-1334-887X, Cooley, Brian C., Robertson, Keith E., Halliday, Crawford A., McClure, John D., Francis, Sheila, Lu, Ruifaug, Kennedy, Simon, George, Sarah J., Wan, Song, Van Rooij, Eva and Baker, Andrew H.;